Nelson Laboratories Acquires Building to Accommodate Growth
Nelson Laboratories announces the acquisition of a new building adjacent to its current facilities that will accommodate immediate and future requirements for capacity and new capabilities.
Nelson Laboratories continues to grow and expand, says Jeffery R. Nelson, president and CEO of Nelson Laboratories. This building acquisition will provide increased space to meet the growing demands of our clients, and will also allow us to add more of what our clients need.
Much of Nelsons growth has been fueled by increased investment in new medical technology, changes in industry guidance and increased regulatory expectations. The testing done at Nelson Laboratories directly supports the development and production of safe medical devices, tissue, drugs, cosmetics and natural products.
The newly acquired 12,000-square-foot building is under renovation to bring it up to Nelson Laboratories rigorous specification. This location will be used to add additional sterilizers used in validation testing, aging chambers for packaging testing and additional space for testing products designed for reuse (such as cleaning, disinfection and steam sterilization of tools, kits or scopes used in hospitals).
Renovation of the new building will be completed in April. New equipment installation is scheduled for April and May. Operations will begin in May.
Â
Unmasking Vaccine Myths: Dr Marschall Runge on Measles, Misinformation, and Public Health Solutions
May 29th 2025As measles cases climb across the US, discredited myths continue to undercut public trust in vaccines. In an exclusive interview with Infection Control Today, Michigan Medicine’s Marschall Runge, PhD, confronts misinformation head-on and explores how clinicians can counter it with science, empathy, and community engagement.
Silent Saboteurs: Managing Endotoxins for Sepsis-Free Sterilization
Invisible yet deadly, endotoxins evade traditional sterilization methods, posing significant risks during routine surgeries. Understanding and addressing their threat is critical for patient safety.
Endoscopes and Lumened Instruments: New Studies Highlight Persistent Contamination Risks
May 7th 2025Two new studies reveal troubling contamination in both new endoscopes and cleaned lumened surgical instruments, challenging the reliability of current reprocessing practices and manufacturer guidelines.
From the Derby to the Decontam Room: Leadership Lessons for Sterile Processing
April 27th 2025Elizabeth (Betty) Casey, MSN, RN, CNOR, CRCST, CHL, is the SVP of Operations and Chief Nursing Officer at Surgical Solutions in Overland, Kansas. This SPD leader reframes preparation, unpredictability, and teamwork by comparing surgical services to the Kentucky Derby to reenergize sterile processing professionals and inspire systemic change.
